1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Transfection Reagents and Equipment Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Transfection Reagents and Equipment Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Popularity of Cell and Gene Therapy
- 5.1.2 Growing Economic Burden of Cancer
5.2 Market Opportunities
- 5.2.1 Ramping Up Small Scale
- 5.2.2 Processes to Large Scale Processes
5.3 Future Trends
- 5.3.1 Strategic Initiatives By Companies
5.4 Impact of Drivers and Restraints
6. Europe Transfection Reagents and Equipment Market Regional Analysis
6.1 Europe Transfection Reagents and Equipment Market Overview
6.2 Europe Transfection Reagents and Equipment Market Revenue 2020-2030 (US$ Million)
6.3 Europe Transfection Reagents and Equipment Market Forecast Analysis
7. Europe Transfection Reagents and Equipment Market Analysis – by Product
7.1 Reagents and Instruments
- 7.1.1 Overview
- 7.1.2 Reagents and Instruments: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Transfection Reagents and Equipment Market Analysis – by Method
8.1 Viral Methods
- 8.1.1 Overview
- 8.1.2 Viral Methods: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Non Viral Methods
- 8.2.1 Overview
- 8.2.2 Non Viral Methods: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybrid Methods
- 8.3.1 Overview
- 8.3.2 Hybrid Methods: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Transfection Reagents and Equipment Market Analysis – by End User
9.1 Academics & Research Institutes and Pharmaceutical & Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Hybrid Methods: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Transfection Reagents and Equipment Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Transfection Reagents and Equipment Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 Europe Transfection Reagents and Equipment Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 UK: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.1.1.2 UK: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.1.1.1.3 UK: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.1.1.2 Germany:
Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Germany: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.1.2.2 Germany: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.1.1.2.3 Germany: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.1.1.3 France:
Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 France: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.1.3.2 France: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.1.1.3.3 France: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.1.1.4 Russia:
Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Russia: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.1.4.2 Russia: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.1.1.4.3 Russia: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.1.1.5 Italy:
Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Italy: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.1.5.2 Italy: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.1.1.5.3 Italy: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.1.1.6 Rest of Europe:
Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.1.1.6.2 Rest of Europe: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.1.1.6.3 Rest of Europe: Europe Transfection Reagents and Equipment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Transfection Reagents and Equipment Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Promega Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bio-Rad Laboratories Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mirus Bio LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 QIAGEN NV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merck KGaA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Lonza Group AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 MaxCyte Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Polyplus-Transfection SA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights